Quantitative in vivo islet potency assay in normoglycemic nude mice correlates with primary graft function after clinical transplantation

Transplantation

Volumn 86, Issue 2, 2008, Pages 360-363

  Caiazzo, Robert ^a,b   Gmyr, Valery ^a,c   Kremer, Bertrand ^a   Hubert, Thomas ^a   Soudan, Benoit ^b   Lukowiak, Bruno ^a,c   Vandewalle, Brigitte ^a   Vantyghem, Marie Christine ^b   Pattou, Francois ^a,b,c   Kerr Conte, Julie ^a,c  

^a INSERM   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c UNIV LILLE   (France)

Author keywords

Human; Islet transplantation; Mouse; Potency assay

Indexed keywords

ADENOSINE TRIPHOSPHATE; C PEPTIDE; GLUCOSE; INSULIN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CASE REPORT; CELL VIABILITY; CLINICAL EVALUATION; CLINICAL TRIAL; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; KIDNEY CAPSULE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ASSAY; RELIABILITY; ANIMAL; CYTOLOGY; EXPERIMENTAL DIABETES MELLITUS; GENE EXPRESSION REGULATION; GRAFT SURVIVAL; INSULIN RESISTANCE; METABOLISM; METHODOLOGY; NUDE MOUSE; PANCREAS ISLET; RADIOIMMUNOASSAY; TIME;

ANIMALS; C-PEPTIDE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; GENE EXPRESSION REGULATION; GRAFT SURVIVAL; HUMANS; INSULIN; INSULIN RESISTANCE; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MICE; MICE, NUDE; RADIOIMMUNOASSAY; TIME FACTORS;

EID: 49249124157     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31817ef846     Document Type: Article

References (16)

1. Shapiro AM, Ricordi C, Hering BJ, et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006; 355: 1318.
2. Bertuzzi F, Ricordi C. Prediction of clinical outcome in islet allotransplantation. Diabetes Care 2007; 30: 410.
3. Hubert T, Gmyr V, Arnalsteen L, et al. Influence of preservation solution on human islet isolation outcome. Transplantation 2007; 83: 270.
4. Ricordi C, Scharp DW, Lacy PE. Reversal of diabetes in nude mice after transplantation of fresh and 7-day-cultured (24 degrees C) human pancreatic islets. Transplantation1988; 45: 994.
5. Vandewalle B, Douillard C, Kerr Conte J, et al. Human pancreatic islet quality control: Easy assessment of metabolic functions. Exp Clin Endocrinol Diabetes 1999; 107: 214.
6. Lehmann R, Zuellig RA, Kugelmeier P, et al. Superiority of small islets in human islet transplantation. Diabetes 2007; 56: 594.
7. Keymeulen B, Gillard P, Mathieu C, et al. Correlation between beta cell mass and glycemic control in type 1 diabetic recipients of islet cell graft. Proc Natl Acad Sci USA 2006; 103: 17444.
8. Ichii H, Inverardi L, Pileggi A, et al. A novel method for the assessment of cellular composition and beta-cell viability in human islet preparations. Am J Transplant 2005; 5: 1635.
9. Goto M, Holgersson J, Kumagai-Braesch M, et al. The ADP/ATP ratio: A novel predictive assay for quality assessment of isolated pancreatic islets. Am J Transplant 2006; 6: 2483.
10. Papas KK, Colton CK, Nelson RA, et al. Human islet oxygen consumption rate and DNA measurements predict diabetes reversal in nude mice. Am J Transplant2007; 7: 707.
11. Hering BJ, Kandaswamy R, Harmon JV, et al. Transplantation of cultured islets from two-layer preserved pancreases in type 1 diabetes with anti-CD3 antibody. Am J Transplant2004; 4: 390.
12. Warnock GL, Kneteman NM, Rajotte RV. Effect of diabetes on the function of transplanted human islets of Langerhans. Transplant Proc 1990; 22: 804.
13. Gaber AO, Fraga D, Kotb M, et al. Human islet graft function in NOD-SCID mice predicts clinical response in islet transplant recipients. Transplant Proc 2004; 36: 1108.
14. Menger MD, Vajkoczy P, Leiderer R, et al. Influence of experimental hyperglycemia on microvascular blood perfusion of pancreatic islet isografts. J Clin Invest 1992; 90: 1361.
15. Prigouris S, Lorentziadis M, Stylogiannis S, et al. Experimental autotransplantation of the parathyroid gland. Br J Surg 1996; 83: 410.
16. Narushima M, Kobayashi N, Okitsu T, et al. A human beta-cell line for transplantation therapy tocontrol type 1 diabetes. Nat Biotechnol 2005; 23: 1274.